Diagnos Laboratorium Utama PT Tbk (DGNS) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.008x

Based on the latest financial reports, Diagnos Laboratorium Utama PT Tbk (DGNS) has a cash flow conversion efficiency ratio of 0.008x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp1.52 Billion ≈ $88.96K USD) by net assets (Rp194.00 Billion ≈ $11.37 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See DGNS defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Diagnos Laboratorium Utama PT Tbk - Cash Flow Conversion Efficiency Trend (2017–2024)

This chart illustrates how Diagnos Laboratorium Utama PT Tbk's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Diagnos Laboratorium Utama PT Tbk Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Diagnos Laboratorium Utama PT Tbk ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
GENOMTEC S.A. ZY -10 F:4VI	N/A
Holista Colltech Ltd AU:HCT	-0.382x
Multi Indocitra Tbk JK:MICE	-0.016x
Telcon Inc KQ:200230	0.013x
Barrel Co. Ltd KQ:267790	-0.054x
Alpha Microelectronics TWO:8024	-0.018x
I Synergy Group Ltd AU:IS3	0.455x
Alliance Nickel Ltd AU:AXN	-0.021x

Annual Cash Flow Conversion Efficiency for Diagnos Laboratorium Utama PT Tbk (2017–2024)

The table below shows the annual cash flow conversion efficiency of Diagnos Laboratorium Utama PT Tbk from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see DGNS stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Rp196.13 Billion ≈ $11.49 Million	Rp27.30 Billion ≈ $1.60 Million	0.139x	+106.49%
2023-12-31	Rp195.59 Billion ≈ $11.46 Million	Rp13.18 Billion ≈ $772.50K	0.067x	+335.77%
2022-12-31	Rp210.43 Billion ≈ $12.33 Million	Rp-6.02 Billion ≈ $-352.51K	-0.029x	-109.80%
2021-12-31	Rp201.80 Billion ≈ $11.82 Million	Rp58.87 Billion ≈ $3.45 Million	0.292x	+10.19%
2020-12-31	Rp99.07 Billion ≈ $5.80 Million	Rp26.23 Billion ≈ $1.54 Million	0.265x	+9.86%
2019-12-31	Rp46.46 Billion ≈ $2.72 Million	Rp11.20 Billion ≈ $656.06K	0.241x	-62.25%
2018-12-31	Rp13.27 Billion ≈ $777.31K	Rp8.47 Billion ≈ $496.20K	0.638x	+388.54%
2017-12-31	Rp3.22 Billion ≈ $188.58K	Rp-712.00 Million ≈ $-41.72K	-0.221x	--

About Diagnos Laboratorium Utama PT Tbk

JK:DGNS Indonesia Diagnostics & Research

Market Cap

$17.43 Million

Rp297.50 Billion IDR

Market Cap Rank

#25561 Global

#546 in Indonesia

Share Price

Rp238.00

Change (1 day)

-3.25%

52-Week Range

Rp140.00 - Rp328.00

All Time High

Rp1408.74